Medacta gains clearance for cervical interbody fusion device

Spinal Tech

The FDA provided Medacta clearance for its Mecta-C Stand Alone anterior cervical fusion device.

Three insights:

1. Mecta-C is designed for use in C2 to T1 in skeletally mature patients suffering from degenerative disc disease.

2. The device's modular design enables surgeons to intraoperatively select four plating options to fit patients' needs.

3. Mecta-C is offered in TiPEEK, a plasma-sprayed titanium coating that improves stability and migration resistance.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers